Arboviruses and Viral Hemorrhagic Fevers (VHF)

Infectious Disease Clinics of North America

Volumn 26, Issue 2, 2012, Pages 479-496

  Meltzer, Eyal ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Alphavirus; Arbovirus; Arenavirus; Bunyavirus; Filovirus; Flavivirus; Viral hemorrhagic fever

Indexed keywords

ANTIVIRUS AGENT; DENGUE VACCINE; RIBAVIRIN;

ARBOVIRUS; ARENAVIRUS; ARTHRALGIA; CALIFORNIA ENCEPHALITIS VIRUS; CHIKUNGUNYA ALPHAVIRUS; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CRIMEAN CONGO HEMORRHAGIC FEVER; DENGUE; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; EASTERN EQUINE ENCEPHALOMYELITIS VIRUS; EBOLA VIRUS; FILOVIRUS; GEOGRAPHIC DISTRIBUTION; HANTAVIRUS; HUMAN; INFECTION PREVENTION; JAPANESE ENCEPHALITIS VIRUS; LA CROSSE VIRUS; LASSA FEVER; LASSA VIRUS; MARBURG VIRUS; NONHUMAN; OROPOUCHE BUNYAVIRUS; ORTHOBUNYAVIRUS; PHLEBOVIRUS; PHLEBOVIRUS INFECTION; RASH; REOVIRUS; REVIEW; RIFT VALLEY FEVER; SEVERE FEVER WITH THROMBOCYTOPENIA SYNDROME; TAHYNA BUNYAVIRUS; TAXONOMY; TICK BORNE ENCEPHALITIS FLAVIVIRUS; TOSCANA VIRUS; TREATMENT DURATION; TREATMENT PLANNING; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; VIRUS HEMORRHAGIC FEVER; VIRUS TRANSMISSION; WEST NILE FLAVIVIRUS; WESTERN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; YELLOW FEVER FLAVIVIRUS;

ANTIVIRAL AGENTS; ARBOVIRUS INFECTIONS; HEMORRHAGIC FEVERS, VIRAL; HUMANS; RIBAVIRIN; VIRAL VACCINES;

EID: 84861469778     PISSN: 08915520     EISSN: 15579824     Source Type: Journal    
DOI: 10.1016/j.idc.2012.02.003     Document Type: Review

References (63)

1. Rush B. An account of the bilious remitting fever, as it appeared in Philadelphia in the summer and autumn of the year 1780. Medical inquiries and observations 1805, 115-134. J. Conrad & Co, Philadelphia, Available at:, Accessed March 25, 2012. http://books.google.com/books?id=y3EFAAAAQAAJ&dq=inauthor%253A%2522Benjamin%2520Rush%2522&hl=iw&pg=PR5v=onepage&q&f=false, B. Rush (Ed.).
2. Erskine J.H. A report on yellow fever as it appeared in Memphis, Tenn., in 1873. Public Health Pap Rep 1873, 1:385-392.
3. WHO investigation commission Ebola haemorrhagic fever in Zaire, 1976. Bull World Health Organ 1978, 56(2):271-293.
4. Petersen L.R., Hayes E.B. West Nile virus in the Americas. Med Clin North Am 2008, 92(6):1307-1322.
5. Dengue haemorrhagic fever: diagnosis, treatment, prevention and control 2009, World Health Organization, Geneva (Switzerland), Available at:, Accessed September 30, 2009. http://whqlibdoc.who.int/publications/2009/9789241547871_eng.pdf, 2nd edition.
6. de Silva A.M., Dittus W.P., Amerasinghe P.H., et al. Serologic evidence for an epizootic dengue virus infecting toque macaques (Macaca sinica) at Polonnaruwa, Sri Lanka. Am J Trop Med Hyg 1999, 60(2):300-306.
7. Rico-Hesse R., Harrison L.M., Salas R.A., et al. Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology 1997, 230(2):244-251.
8. Brunkard J.M., Robles López J.L., Ramirez J., et al. Dengue fever seroprevalence and risk factors, Texas-Mexico border, 2004. Emerg Infect Dis 2007, 13(10):1477-1483.
9. Gjenero-Margan I., Aleraj B., Krajcar D., et al. Autochthonous dengue fever in Croatia, August-September 2010. Euro Surveill 2011, 16(9). pii-19805. Available at:, Accessed March 25, 2012. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19805.
10. La Ruche G., Souarès Y., Armengaud A., et al. First two autochthonous dengue virus infections in metropolitan France, September 2010. Euro Surveill 2010, 15(39):19676.
11. Tomori O. Yellow fever in Africa: public health impact and prospects for control in the 21st century. Biomedica 2002, 22(2):178-210.
12. Misra U.K., Kalita J. Overview: Japanese encephalitis. Prog Neurobiol 2010, 91(2):108-120.
13. Romero J.R., Newland J.G. Viral meningitis and encephalitis: traditional and emerging viral agents. Semin Pediatr Infect Dis 2003, 14(2):72-82.
14. Kopel E., Amitai Z., Bin H., et al. Surveillance of West Nile Virus Disease, Tel Aviv District, Israel, 2005 to 2010. Euro Surveill 2011, 16(25). pii-19894. Available at:, Accessed March 25, 2012. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19894.
15. May F.J., Davis C.T., Tesh R.B., et al. Phylogeography of West Nile virus: from the cradle of evolution in Africa to Eurasia, Australia, and the Americas. J Virol 2011, 85(6):2964-2974.
16. Lasala P.R., Holbrook M. Tick-borne flaviviruses. Clin Lab Med 2010, 30(1):221-235.
17. Ergunay K., Ozer N., Us D., et al. Seroprevalence of West Nile virus and tick-borne encephalitis virus in Southeastern Turkey: first evidence for tick-borne encephalitis virus infections. Vector Borne Zoonotic Dis 2007, 7(2):157-161.
18. Pugliese A., Beltramo T., Torre D. Seroprevalence study of tick-borne encephalitis, Borrelia burgdorferi, dengue and Toscana virus in Turin Province. Cell Biochem Funct 2007, 25(2):185-188.
19. Jentes E.S., Robinson J., Johnson B.W., et al. Acute arboviral infections in Guinea, West Africa, 2006. Am J Trop Med Hyg 2010, 83(2):388-394.
20. Lu Z., Lu X.J., Fu S.H., et al. Tahyna virus and human infection, China. Emerg Infect Dis 2009, 15(2):306-309.
21. Mourãão M.P., Bastos M.S., Gimaqu J.B., et al. Oropouche fever outbreak, Manaus, Brazil, 2007-2008. Emerg Infect Dis 2009, 15(12):2063-2064.
22. Forshey B.M., Guevara C., Laguna-Torres V.A., NMRCD Febrile Surveillance Working Group, et al. Arboviral etiologies of acute febrile illnesses in Western South America, 2000-2007. PLoS Negl Trop Dis 2010, 4(8):e787.
23. WHO. Crimean-Congo haemorrhagic fever (CCHF) Fact sheet and map. Available at: Accessed September 30, 2011. http://www.who.int/csr/disease/crimean_congoHF/en/on.
24. Cusi M.G., Savellini G.G., Zanelli G. Toscana virus epidemiology: from Italy to beyond. Open Virol J 2010, 4:22-28.
25. Yu X.J., Liang M.F., Zhang S.Y., et al. Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med 2011, 364(16):1523-1532.
26. Liu Y., Li Q., Hu W., et al. Person-to-person transmission of severe fever with thrombocytopenia syndrome virus. Vector Borne Zoonotic Dis 2012, 12(2):156-160.
27. Clements A.C., Pfeiffer D.U., Martin V., et al. A Rift Valley fever atlas for Africa. Prev Vet Med 2007, 82(1-2):72-82.
28. Madani T.A., Al-Mazrou Y.Y., Al-Jeffri M.H., et al. Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics. Clin Infect Dis 2003, 37(8):1084-1092.
29. WHO Rift Valley fever, South Africa - update. Wkly Epidemiol Rec 2010, 85(21):185-186.
30. Attoui H., Mohd Jaafar F., de Micco P., et al. Coltiviruses and Seadornaviruses in North America, Europe, and Asia. Emerg Infect Dis 2005, 11(11):1673-1679.
31. Charrel R.N., Attoui H., Butenko A.M., et al. Tick-borne virus diseases of human interest in Europe. Clin Microbiol Infect 2004, 10(12):1040-1055.
32. Liu H., Li M.H., Zhai Y.G., et al. Banna virus, China, 1987-2007. Emerg Infect Dis 2010, 16(3):514-517.
33. Hammon W.M., Rudnick A., Sather G.E. Viruses associated with epidemic hemorrhagic fevers of the Philippines and Thailand. Science 1960, 131:1102-1103.
34. Pialoux G., Gaüzère B.A., Jauréguiberry S., et al. Chikungunya, an epidemic arbovirosis. Lancet Infect Dis 2007, 7(5):319-327.
35. Tsetsarkin K.A., Chen R., Leal G., et al. Chikungunya virus emergence is constrained in Asia by lineage-specific adaptive landscapes. Proc Natl Acad Sci U S A 2011, 108(19):7872-7877.
36. Rezza G., Nicoletti L., Angelini R., CHIKV study group, et al. Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet 2007, 370(9602):1840-1846.
37. Grandadam M., Caro V., Plumet S., et al. Chikungunya virus, southeastern France. Emerg Infect Dis 2011, 17(5):910-913.
38. Mathiot C.C., Grimaud G., Garry P., et al. An outbreak of human Semliki Forest virus infections in Central African Republic. Am J Trop Med Hyg 1990, 42(4):386-393.
39. Mourão M.P., Bastos M.D., de Figueiredo R.P., et al. Mayaro fever in the city of Manaus, Brazil, 2007-2008. Vector Borne Zoonotic Dis 2012, 12(1):42-46.
40. Australian Government Department of Health and Ageing, the Communicable Diseases Network Australia Arboviral diseases and malaria in Australia, 2008-09: annual report of the National Arbovirus and Malaria Advisory Committee. Commun Dis Intell 2010, 34(3):225-241. Available at:, Accessed October 01, 2011. http://www.health.gov.au/internet/main/publishing.nsf/content/cda-cdi3403b.htm.
41. Sane J., Guedes S., Kurkela S., et al. Epidemiological analysis of mosquito-borne Pogosta disease in Finland, 2009. Euro Surveill 2010, 15(2). pii-19462. Available at:, Accessed March 25, 2012. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19462.
42. Weaver S.C., Salas R., Rico-Hesse R., et al. Re-emergence of epidemic Venezuelan equine encephalomyelitis in South America. VEE study group. Lancet 1996, 348(9025):436-440.
43. Aguilar P.V., Estrada-Franco J.G., Navarro-Lopez R., et al. Endemic Venezuelan equine encephalitis in the Americas: hidden under the dengue umbrella. Future Virol 2011, 6(6):721-740.
44. Groseth A., Feldmann H., Strong J.E. The ecology of Ebola virus. Trends Microbiol 2007, 15(9):408-416.
45. Richards G.A., Murphy S., Jobson R., et al. Unexpected Ebola virus in a tertiary setting: clinical and epidemiologic aspects. Crit Care Med 2000, 28(1):240-244.
46. Bausch D.G., Nichol S.T., Muyembe-Tamfum J.J., International Scientific and Technical Committee for Marburg Hemorrhagic Fever Control in the Democratic Republic of the Congo, et al. Marburg hemorrhagic fever associated with multiple genetic lineages of virus. N Engl J Med 2006, 355(9):909-919.
47. Jeffs B., Roddy P., Weatherill D., et al. The Medecins Sans Frontieres intervention in the Marburg hemorrhagic fever epidemic, Uige, Angola, 2005. I. Lessons learned in the hospital. J Infect Dis 2007, 196(Suppl 2):S154-S161.
48. Ogbu O., Ajuluchukwu E., Uneke C.J. Lassa fever in West African sub-region: an overview. J Vector Borne Dis 2007, 44(1):1-11.
49. Armstrong L.R., Dembry L.M., Rainey P.M., et al. Management of a Sabiá virus-infected patients in a US hospital. Infect Control Hosp Epidemiol 1999, 20(3):176-182.
50. Kilgore P.E., Peters C.J., Mills J.N., et al. Prospects for the control of Bolivian hemorrhagic fever. Emerg Infect Dis 1995, 1(3):97-100.
51. Liu X., Jiang B., Bi P., et al. Prevalence of haemorrhagic fever with renal syndrome in mainland China: analysis of national surveillance data, 2004-2009. Epidemiol Infect 2011, 1-7. [Epub ahead of print].
52. Heyman P., Ceianu C.S., Christova I., et al. A five-year perspective on the situation of haemorrhagic fever with renal syndrome and status of the hantavirus reservoirs in Europe, 2005-2010. Euro Surveill 2011, 16(36). pii-19961. Available at:, Accessed March 25, 2012. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19961.
53. Clement J., Maes P., van Ypersele de Strihou C., et al. Beechnuts and outbreaks of nephropathia epidemica (NE): of mast, mice and men. Nephrol Dial Transplant 2010, 25(6):1740-1746.
54. Zhang Y.Z., Dong X., Li X., et al. Seoul virus and hantavirus disease, Shenyang, People's Republic of China. Emerg Infect Dis 2009, 15(2):200-206.
55. Macneil A., Nichol S.T., Spiropoulou C.F. Hantavirus pulmonary syndrome. Virus Res 2011, 162(1-2):138-147.
56. Armien B., Pascale J.M., Munoz C., et al. Incidence rate for hantavirus infections without pulmonary syndrome, Panama. Emerg Infect Dis 2011, 17(10):1936-1939.
57. Larrieu S., Pouderoux N., Pistone T., et al. Factors associated with persistence of arthralgia among chikungunya virus-infected travellers: report of 42 French cases. J Clin Virol 2010, 47(1):85-88.
58. Manimunda S.P., Vijayachari P., Uppoor R., et al. Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging. Trans R Soc Trop Med Hyg 2010, 104(6):392-399.
59. McCormick J.B., King I.J., Webb P.A., et al. Lassa fever. Effective therapy with ribavirin. N Engl J Med 1986, 314(1):20-26.
60. Kilgore P.E., Ksiazek T.G., Rollin P.E., et al. Treatment of Bolivian hemorrhagic fever with intravenous ribavirin. Clin Infect Dis 1997, 24(4):718-722.
61. Rusnak J.M., Byrne W.R., Chung K.N., et al. Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea. Antiviral Res 2009, 81(1):68-76.
62. Mertz G.J., Miedzinski L., Goade D., Collaborative Antiviral Study Group, et al. Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America. Clin Infect Dis 2004, 39(9):1307-1313.
63. Guy B., Barrere B., Malinowski C., et al. From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine. Vaccine 2011, 29(42):7229-7241.